Send to

Choose Destination
See comment in PubMed Commons below
Dermatol Clin. 2013 Jul;31(3):495-506. doi: 10.1016/j.det.2013.04.006. Epub 2013 May 25.

Type 2 diabetes mellitus: a metabolic autoinflammatory disease.

Author information

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 3 Blegdamsvej, DK-2200 Copenhagen N, Denmark.


The recent molecular, biologic, and genetic understanding of the inflammasome has revolutionized the diagnosis of and therapy for the phenotypically heterogeneous group of rare oligogenic disorders, now recognized to have autoinflammatory origin. This article reviews the importance of inflammasome activation in the central and peripheral mechanisms underlying a common, multifactorial, lifestyle-related, and polygenetic disease (type 2 diabetes mellitus), and conceptualizes the notion that this health challenge should now be recognized to have an autoinflammatory cause. It is hoped that targeting these mechanisms will enable the introduction of novel therapies that attack the basic pathogenetic mechanisms of type 2 diabetes mellitus rather than the epiphenomena that are its consequences.


Beta-cell; Cytokines; Insulin resistance; Interleukin-1; Islets; Low-grade inflammation; Macrophage; Pancreas

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center